Literature DB >> 21551225

NFBD1/MDC1 regulates Cav1 and Cav2 independently of DNA damage and p53.

Kathleen A Wilson1, Sierra A Colavito, Vincent Schulz, Patricia Heffernan Wakefield, William Sessa, David Tuck, David F Stern.   

Abstract

NFBD1/MDC1 is involved in DNA damage checkpoint signaling and DNA repair. NFBD1 binds to the chromatin component γH2AX at sites of DNA damage, causing amplification of ataxia telangiectasia-mutated gene (ATM) pathway signaling and recruitment of DNA repair factors. Residues 508-995 of NFBD1 possess transactivation activity, suggesting a possible role of NFBD1 in transcription. Furthermore, NFBD1 influences p53-mediated transcription in response to adriamycin. We sought to determine the role of NFBD1 in ionizing radiation (IR)-responsive transcription and if NFBD1 influences transcription independently of p53. Using microarray analysis, we identified genes altered upon NFBD1 knockdown. Surprisingly, most NFBD1 regulated genes are regulated in both the absence and presence of IR, thus pointing toward a novel function for NFBD1 outside of the DNA damage response. Furthermore, NFBD1 knockdown regulated genes mostly independent of p53 knockdown. These genes are involved in pathways including focal adhesion signaling, carbohydrate metabolism, and insulin signaling. We found that CAV1 and CAV2 mRNA and protein levels are reduced by both NFBD1 knockdown and knockout independently of IR and p53. NFBD1-depleted cells exhibit some similar phenotypes to Cav1-depleted cells. Furthermore, like Cav1-depletion, NFBD1 shRNA increases Erk phosphorylation. Thus, Cav1 could act as a mediator of the DNA-damage independent effects of NFBD1 in mitogenic signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21551225      PMCID: PMC3901581          DOI: 10.1158/1541-7786.MCR-10-0317

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  57 in total

Review 1.  Caveolins, liquid-ordered domains, and signal transduction.

Authors:  E J Smart; G A Graf; M A McNiven; W C Sessa; J A Engelman; P E Scherer; T Okamoto; M P Lisanti
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals.

Authors:  Zhenkun Lou; Katherine Minter-Dykhouse; Sonia Franco; Monica Gostissa; Melissa A Rivera; Arkady Celeste; John P Manis; Jan van Deursen; André Nussenzweig; Tanya T Paull; Frederick W Alt; Junjie Chen
Journal:  Mol Cell       Date:  2006-01-20       Impact factor: 17.970

3.  NFBD1, a novel nuclear protein with signature motifs of FHA and BRCT, and an internal 41-amino acid repeat sequence, is an early participant in DNA damage response.

Authors:  Yong Lei Shang; Amanda J Bodero; Phang-Lang Chen
Journal:  J Biol Chem       Date:  2002-12-09       Impact factor: 5.157

4.  Reduction of caveolin and caveolae in oncogenically transformed cells.

Authors:  A J Koleske; D Baltimore; M P Lisanti
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

5.  NFBD1/KIAA0170 is a novel nuclear transcriptional transactivator with BRCT domain.

Authors:  T Ozaki; T Nagase; S Ichimiya; N Seki; M Ohiri; N Nomura; N Takada; S Sakiyama; B L Weber; A Nakagawara
Journal:  DNA Cell Biol       Date:  2000-08       Impact factor: 3.311

6.  MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways.

Authors:  Zhenkun Lou; Katherine Minter-Dykhouse; Xianglin Wu; Junjie Chen
Journal:  Nature       Date:  2003-02-27       Impact factor: 49.962

7.  Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS.

Authors:  Erin R P Shull; Youngsoo Lee; Hironobu Nakane; Travis H Stracker; Jingfeng Zhao; Helen R Russell; John H J Petrini; Peter J McKinnon
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

8.  NFBD1/MDC1 regulates ionizing radiation-induced focus formation by DNA checkpoint signaling and repair factors.

Authors:  Xingzhi Xu; David F Stern
Journal:  FASEB J       Date:  2003-10       Impact factor: 5.191

9.  Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation.

Authors:  Zuzana Horejsí; Jacob Falck; Christopher J Bakkenist; Michael B Kastan; Jiri Lukas; Jiri Bartek
Journal:  Oncogene       Date:  2004-04-15       Impact factor: 9.867

10.  Caveolin-1 regulates cell polarization and directional migration through Src kinase and Rho GTPases.

Authors:  Araceli Grande-García; Asier Echarri; Johan de Rooij; Nazilla B Alderson; Clare M Waterman-Storer; José M Valdivielso; Miguel A del Pozo
Journal:  J Cell Biol       Date:  2007-05-21       Impact factor: 10.539

View more
  6 in total

Review 1.  Contributions of Rad9 to tumorigenesis.

Authors:  Constantinos G Broustas; Howard B Lieberman
Journal:  J Cell Biochem       Date:  2012-03       Impact factor: 4.429

2.  mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms.

Authors:  Kathleen A Wilson-Edell; Mariya A Yevtushenko; Daniel E Rothschild; Aric N Rogers; Christopher C Benz
Journal:  Breast Cancer Res Treat       Date:  2014-02-22       Impact factor: 4.624

3.  MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer.

Authors:  Chunyu Wang; Hongmiao Sun; Renlong Zou; Tingting Zhou; Shengli Wang; Shiying Sun; Changci Tong; Hao Luo; Yanshu Li; Zhenhua Li; Enhua Wang; Yuhua Chen; Liu Cao; Feng Li; Yue Zhao
Journal:  Nucleic Acids Res       Date:  2015-04-30       Impact factor: 16.971

4.  NFBD1/MDC1 is phosphorylated by PLK1 and controls G2/M transition through the regulation of a TOPOIIα-mediated decatenation checkpoint.

Authors:  Kiyohiro Ando; Toshinori Ozaki; Toru Hirota; Akira Nakagawara
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

5.  RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth.

Authors:  Kathleen A Wilson-Edell; Amanuel Kehasse; Gary K Scott; Christina Yau; Daniel E Rothschild; Birgit Schilling; Bianca S Gabriel; Mariya A Yevtushenko; Ingrid M Hanson; Jason M Held; Bradford W Gibson; Christopher C Benz
Journal:  Oncotarget       Date:  2014-07-15

6.  A Newfound association between MDC1 functional polymorphism and lung cancer risk in Chinese.

Authors:  Bo Wang; Lisha Zhang; Fuman Qiu; Wenxiang Fang; Jieqiong Deng; Yifeng Zhou; Jiachun Lu; Lei Yang
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.